COMPARISON OF THE RECEPTOR BINDING CHARACTERISTICS OF OPIATE AGONISTS INTERACTING WITH μ- OR K-RECEPTORS (original) (raw)

Differential effects of sodium on two types of opiate binding sites

Tai Akera

Life Sciences, 1975

View PDFchevron_right

Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists

Jonathan Katz

Life Sciences, 1983

View PDFchevron_right

effect of α-adrenergic blockers on naloxone-binding in braiN

Theodore Cicero

Biochemical Pharmacology, 1974

View PDFchevron_right

Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine

Richard Bodnar

Psychopharmacology, 1988

View PDFchevron_right

Naloxonazine actions in vivo

Janet Clark

European Journal of Pharmacology, 1986

View PDFchevron_right

Improved assays for the assessment of ϰ- and δ-properties of opioid ligands

susan j ward

European Journal of Pharmacology, 1982

View PDFchevron_right

Opiate receptors: an introduction

John Carmody

Anaesthesia and intensive care, 1987

View PDFchevron_right

Study on the Activation of the Opioid Receptors by a Set of Morphine Derivatives in a Well-Defined Assay System

Olivier Civelli

Neurochemical Research, 2012

View PDFchevron_right

Ketamine-Induced Potentiation of Morphine Analgesia in Rat Tail-Flick Test: Role of Opioid-, α2-Adrenoceptors and ATP-Sensitive Potassium Channels

Vietla Rao

Biological & Pharmaceutical Bulletin, 2006

View PDFchevron_right

The sensitivity of opioid receptor types to regulation by sodium and GTP

Stephen Brown

Neuropeptides, 1984

View PDFchevron_right

Regional saturation studies of [3H]naloxone binding in the naive, dependent and withdrawal states

William Geary

Brain Research, 1985

View PDFchevron_right

Pharmacological characterization of the binding of [ 3 H]bremazocine in guinea-pig brain: evidence for multiplicity of the κ-opioid receptors

Mario Tiberi

Canadian Journal of Physiology and Pharmacology, 1989

View PDFchevron_right

Morphine and naloxone act similarly on glutamate-caused guinea pig ileum contraction

Yagiz Uresin

Pharmacology Biochemistry and Behavior, 1992

View PDFchevron_right

Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity

Frank LaBella

Brain Research, 1979

View PDFchevron_right

Subgroups among μ-opioid receptor agonists distinguished by ATP-sensitive K+ channel-acting drugs

José Baeyens

British Journal of Pharmacology, 1995

View PDFchevron_right

The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine

robert I cohen

Life Sciences, 1993

View PDFchevron_right

Characterization of prototypical opioid antagonists, agonist-antagonists, and agonists in the morphine-dependent rhesus monkey

Mario D Aceto

Neuropeptides, 1984

View PDFchevron_right

Opioid Receptors: Ligand-Dependent Activation of Potassium Conductance, Desensitization, and Internalization

Jennifer Whistler

2000

View PDFchevron_right

Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors

Maria Concetta Olianas

British Journal of Pharmacology, 2006

View PDFchevron_right

Chronic administration of morphine and naltrexone up-regulate μ-opioid binding sites labeled by [3H][D-Ala2, MePhe4, Gly-ol5]enkephalin: further evidence for two μ-binding sites

Kenner Rice

European Journal of Pharmacology, 1989

View PDFchevron_right

Chronic opioid antagonist treatment: assessment of receptor upregulation

VICTOR SIERRA

European Journal of Pharmacology, 1989

View PDFchevron_right

Multiple opiate receptors in the guinea pig enteric nervous system: unmasking the copresence of receptor subtypes

Alan Gintzler

Proceedings of the National Academy of Sciences, 1984

View PDFchevron_right

[3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine

Theodore Cicero

Life Sciences, 1988

View PDFchevron_right

CLINICAL PHARMACOLOGY OF NARCOTIC ANTAGONISTS

George Woody

Annals of the New York Academy of Sciences, 1978

View PDFchevron_right

Increased antagonist potency of naloxone caused by morphine pretreatment in mice

G. Bentley

European Journal of Pharmacology, 1978

View PDFchevron_right

PHARMACOKINETICS INVOLVED WITH KAPPA OPIOID RECEPTORS (Atena Editora)

Atena Editora

PHARMACOKINETICS INVOLVED WITH KAPPA OPIOID RECEPTORS (Atena Editora), 2022

View PDFchevron_right

Effect of κ-opioid receptor agonists on morphine analgesia in morphine-naive and morphine-tolerant rats

Ramarao Poduri

European Journal of Pharmacology, 1988

View PDFchevron_right

An analysis of naltrexone and naloxone's possible agonistic action in the dog

Joseph Wettstein

View PDFchevron_right

Binding of β-Carbolines and Tetrahydroisoquinolines by Opiate Receptors of the δ-Type

Veijo Saano

Acta Pharmacologica et Toxicologica, 1984

View PDFchevron_right

Opiate radioreceptor assay distinguishes between anesthetics and convulsants: the effect of pH

Frank LaBella

Brain Research, 1982

View PDFchevron_right

Receptors for morphine and opioids

Emilio Alejandro Hazas sanchez

General Pharmacology: The Vascular System, 1976

View PDFchevron_right

Interaction of tricyclic antidepressants with opiate receptors

Irving Wainer

Biochemical Pharmacology, 1980

View PDFchevron_right

The distribution of multiple opiate receptors in bovine brain

Mary Ninkovic

Brain Research, 1981

View PDFchevron_right

μ-Opioid Receptors: Ligand-Dependent Activation of Potassium Conductance, Desensitization, and Internalization

Abdallah salem

The Journal of Neuroscience, 2002

View PDFchevron_right